Jilin Oriental Pharmaceutical

Jilin Oriental Pharmaceutical is a Chinese pharmaceutical company founded in 1988 and headquartered in Changchun, Jilin Province. The company specializes in the development, manufacture, and distribution of Traditional Chinese Medicines (TCM) and western chemical preparations. Its core product portfolio includes treatments for cardiovascular disease, respiratory ailments, and gynecological conditions, with its flagship product being Xuezhitong Capsules for the treatment of hyperlipidemia. Jilin Oriental operates GMP-certified manufacturing facilities and focuses on integrating modern biotechnology with traditional herbal medicine to serve the domestic Chinese market.